These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8097165)

  • 1. The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxiety.
    Costall B; Domeney AM; Kelly ME; Tomkins DM; Naylor RJ; Wong EH; Smith WL; Whiting RL; Eglen RM
    Eur J Pharmacol; 1993 Mar; 234(1):91-9. PubMed ID: 8097165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zacopride: anxiolytic profile in rodent and primate models of anxiety.
    Costall B; Domeney AM; Gerrard PA; Kelly ME; Naylor RJ
    J Pharm Pharmacol; 1988 Apr; 40(4):302-5. PubMed ID: 2900320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of DAU 6215, a novel 5HT-3 antagonist, in animal models of anxiety.
    Borsini F; Brambilla A; Cesana R; Donetti A
    Pharmacol Res; 1993; 27(2):151-64. PubMed ID: 8097309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.
    Rodgers RJ; Cole JC; Tredwell JM
    Psychopharmacology (Berl); 1995 Feb; 117(3):306-12. PubMed ID: 7770606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour.
    Barnes NM; Costall B; Ge J; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1992 Jul; 218(1):15-25. PubMed ID: 1356806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural studies on WAY100289, a novel 5-HT3 receptor antagonist, in two animal models of anxiety.
    Bill DJ; Fletcher A; Glenn BD; Knight M
    Eur J Pharmacol; 1992 Aug; 218(2-3):327-34. PubMed ID: 1358637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.
    Blackburn TP; Baxter GS; Kennett GA; King FD; Piper DC; Sanger GJ; Thomas DR; Upton N; Wood MD
    Psychopharmacology (Berl); 1993; 110(3):257-64. PubMed ID: 7831418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model.
    Barnes NM; Cheng CH; Costall B; Ge J; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1992 Jul; 218(1):91-100. PubMed ID: 1356807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo.
    Eglen RM; Lee CH; Smith WL; Johnson LG; Whiting RL; Hegde SS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):535-43. PubMed ID: 8355189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
    Costall B; Domeney AM; Farre AJ; Kelly ME; Martinez L; Naylor RJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):90-8. PubMed ID: 1352556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketotifen and its analogues reduce aversive responding in the rodent.
    Barnes NM; Costall B; Kelly ME; Onaivi ES; Naylor RJ
    Pharmacol Biochem Behav; 1990 Dec; 37(4):785-93. PubMed ID: 1965515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
    Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
    Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.
    Bill DJ; Coleman J; Hallett I; Middlefell VC; Rhodes KF; Fletcher A
    Br J Pharmacol; 1995 Jul; 115(5):775-80. PubMed ID: 8548176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced anxiolytic effect of zacopride enantiomers in diazepam-withdrawn rats.
    File SE; Andrews N
    Eur J Pharmacol; 1993 Jun; 237(1):127-30. PubMed ID: 8102974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage.
    Gao B; Cutler MG
    Neuropharmacology; 1992 Aug; 31(8):743-8. PubMed ID: 1356251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic potential of 5-HT3 receptor antagonists.
    Costall B; Naylor RJ
    Pharmacol Toxicol; 1992 Mar; 70(3):157-62. PubMed ID: 1349746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential activities of R (+)- and S(-)-zacopride as 5-HT3 receptor antagonists.
    Barnes JM; Barnes NM; Costall B; Domeney AM; Johnson DN; Kelly ME; Munson HR; Naylor RJ; Young R
    Pharmacol Biochem Behav; 1990 Dec; 37(4):717-27. PubMed ID: 2128757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
    Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic-like effects observed in rats exposed to the elevated zero-maze following treatment with 5-HT2/5-HT3/5-HT4 ligands.
    Bell R; Duke AA; Gilmore PE; Page D; Bègue L
    Sci Rep; 2014 Jan; 4():3881. PubMed ID: 24457553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
    Waeber C; Pinkus LM; Palacios JM
    Eur J Pharmacol; 1990 Jun; 181(3):283-7. PubMed ID: 2384135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.